Ryan Asay | Vice President-Corporate Affairs |
David Meek | Chief Executive Officer |
Ben Hickey | Chief Commercial Officer |
Alan Sandler | Chief Medical Officer |
Jamie Christensen | Chief Scientific Officer |
Laurie Stelzer | Chief Financial Officer |
Michael Schmidt | Guggenheim |
Tyler Van Buren | TD Cowen |
Gena Wang | Barclays |
Jonathan Miller | Evercore ISI |
Mike Ulz | Morgan Stanley |
Ben Burnett | Stifel |
Maury Raycroft | Jefferies |
Silvan Tuerkcan | JMP Securities |
Eric Joseph | JPMorgan |
Yigal Nochomovitz | Citi |
Andy Fleszar | B. Riley Securities |
Jay Olson | Oppenheimer |
Ami Fadia | Needham |
Good afternoon, and welcome to the Mirati Therapeutics First Quarter 2023 Earnings Call. My name is Justin, and I will be the operator for today’s call. [Operator Instructions]
It is my pleasure to introduce Ryan Asay, Vice President of Corporate Affairs at Mirati. Ryan, you may begin the call.